(Q44281592)

1 December 2017

title

188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia (English)

1 reference

1 December 2017

1 reference

1 reference

Donald Bunjes

1

1 reference

1 December 2017

publication date

1 November 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

43

1 reference

1 December 2017

issue

11

1 reference

1 December 2017

page(s)

2125-2131

1 reference

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000033015

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000033015

Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000033015

Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000033015

Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000033015

Recent advances in bone marrow scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000033015

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000033015

Treatment of lymphoma with radiolabeled antibody: elimination of tumor cells lacking target antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000033015

Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000033015

10.1080/1042819021000033015

21 January 2018

Identifiers

DOI

1 reference

release_fnb6lgvbh5h2vbnxi4txoronke

1 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fnb6lgvbh5h2vbnxi4txoronke

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference